Ivonescimab trial data in biliary tract cancer to be shown at ESMO 2026

Go back to Ivonescimab trial data in biliary tract cancer to be shown at ESMO 2026
Stratcomm Media, Ltd. (NASDAQ: SMMT) Delayed: 17.59 +0.42 (2.45%)
Previous Close $17.17    52 Week High $19.75 
Open $17.36    52 Week Low $4.26 
Day High $17.62    P/E N/A 
Day Low $16.82    EPS $0.00 
Volume 5,754,954